We are transforming fingerprints into a scalable digital biomarker for rare disease screening. Through artificial intelligence and image analysis, fingerprint patterns are examined to identify specific deviations associated with certain rare genetic syndromes. The solution will be accessible via a mobile application, offering rapid, low-cost, and non-invasive screening. We aim to improve global access to diagnosis, support early intervention and treatment, and provide healthcare systems with a powerful decision-support tool where genetic testing and specialized expertise are limited.
MYNSTUR Diagnostics 